23 August 2023 - Responses to the first public consultation for the HTA Review (Consultation 1) have now been published ...
18 August 2023 - Recommendations made by the PBAC in July 2023 relating to the listing of medicines on the ...
14 August 2023 - Additional documents are now available. ...
2 August 2023 - Multiple new documents are now available. ...
26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...
18 July 2023 - The DoH has chosen to publish another version after the event. ...
14 July 2023 - The public summary documents (first time decisions not to recommend and deferrals) from the March 2023 PBAC ...
11 July 2023 - In an out of session consideration, the PBAC has recommended changes to the restriction criteria and eligible ...
30 June 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2023 PBAC ...
30 June 2023 - More documents are now available. ...
28 June 2023 - 2023-24 Pharmaceutical Benefits Scheme and National Immunisation Program cost recovery fees commence on 1 July 2023. ...
23 June 2023 - In an out of session consideration, the PBAC has recommended changes to the circumstances under which nirmatrelvir ...
16 June 2023 - The outcomes from the May 2023 PBAC intracycle meeting are now available. ...
9 June 2023 - The following documents are now available: ...
18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...